391 related articles for article (PubMed ID: 15558796)
21. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
[TBL] [Abstract][Full Text] [Related]
22. Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.
Kauff ND; Brogi E; Scheuer L; Pathak DR; Borgen PI; Hudis CA; Offit K; Robson ME
Cancer; 2003 Apr; 97(7):1601-8. PubMed ID: 12655515
[TBL] [Abstract][Full Text] [Related]
23. Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening.
Palomba G; Pisano M; Cossu A; Budroni M; Dedola MF; Farris A; Contu A; Baldinu P; Tanda F; Palmieri G
Cancer; 2005 Sep; 104(6):1172-9. PubMed ID: 16047344
[TBL] [Abstract][Full Text] [Related]
24. Factors increasing local recurrence in breast-conserving surgery.
Fatouros M; Roukos DH; Arampatzis I; Sotiriadis A; Paraskevaidis E; Kappas AM
Expert Rev Anticancer Ther; 2005 Aug; 5(4):737-45. PubMed ID: 16111473
[TBL] [Abstract][Full Text] [Related]
25. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
[TBL] [Abstract][Full Text] [Related]
26. A comparison of bilateral breast cancers in BRCA carriers.
Weitzel JN; Robson M; Pasini B; Manoukian S; Stoppa-Lyonnet D; Lynch HT; McLennan J; Foulkes WD; Wagner T; Tung N; Ghadirian P; Olopade O; Isaacs C; Kim-Sing C; Møller P; Neuhausen SL; Metcalfe K; Sun P; Narod SA
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1534-8. PubMed ID: 15941968
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.
Pierce L
Semin Radiat Oncol; 2002 Oct; 12(4):352-61. PubMed ID: 12382193
[TBL] [Abstract][Full Text] [Related]
28. Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.
Murphy RX; Adkinson JM; Namey T; Eid S; Bleznak A
Ann Plast Surg; 2010 May; 64(5):684-7. PubMed ID: 20395792
[TBL] [Abstract][Full Text] [Related]
29. Improved survival in women with BRCA-associated ovarian carcinoma.
Cass I; Baldwin RL; Varkey T; Moslehi R; Narod SA; Karlan BY
Cancer; 2003 May; 97(9):2187-95. PubMed ID: 12712470
[TBL] [Abstract][Full Text] [Related]
30. Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.
Rueth NM; McMahon M; Arrington AK; Swenson K; Leach J; Tuttle TM
Ann Surg Oncol; 2011 Sep; 18(9):2515-20. PubMed ID: 21424371
[TBL] [Abstract][Full Text] [Related]
31. The development of interval breast malignancies in patients with BRCA mutations.
Komenaka IK; Ditkoff BA; Joseph KA; Russo D; Gorroochurn P; Ward M; Horowitz E; El-Tamer MB; Schnabel FR
Cancer; 2004 May; 100(10):2079-83. PubMed ID: 15139048
[TBL] [Abstract][Full Text] [Related]
32. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.
Pierce LJ; Levin AM; Rebbeck TR; Ben-David MA; Friedman E; Solin LJ; Harris EE; Gaffney DK; Haffty BG; Dawson LA; Narod SA; Olivotto IA; Eisen A; Whelan TJ; Olopade OI; Isaacs C; Merajver SD; Wong JS; Garber JE; Weber BL
J Clin Oncol; 2006 Jun; 24(16):2437-43. PubMed ID: 16636335
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT).
Vu-Nishino H; Tavassoli FA; Ahrens WA; Haffty BG
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1040-7. PubMed ID: 15990007
[TBL] [Abstract][Full Text] [Related]
34. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
35. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC
Cancer; 2005 Nov; 104(9):1840-8. PubMed ID: 16136599
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?
Leunen K; Drijkoningen M; Neven P; Christiaens MR; Van Ongeval C; Legius E; Amant F; Berteloot P; Vergote I
Breast Cancer Res Treat; 2008 Jan; 107(1):79-86. PubMed ID: 17431765
[TBL] [Abstract][Full Text] [Related]
37. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Musolino A; Bella MA; Bortesi B; Michiara M; Naldi N; Zanelli P; Capelletti M; Pezzuolo D; Camisa R; Savi M; Neri TM; Ardizzoni A
Breast; 2007 Jun; 16(3):280-92. PubMed ID: 17257844
[TBL] [Abstract][Full Text] [Related]
38. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
Fatouros M; Baltoyiannis G; Roukos DH
Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
[TBL] [Abstract][Full Text] [Related]
39. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
[TBL] [Abstract][Full Text] [Related]
40. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
Metcalfe KA; Lynch HT; Ghadirian P; Tung N; Olivotto IA; Foulkes WD; Warner E; Olopade O; Eisen A; Weber B; McLennan J; Sun P; Narod SA
Gynecol Oncol; 2005 Jan; 96(1):222-6. PubMed ID: 15589605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
